Skip to main content
. 2020 Oct 28;6(5):1–6. doi: 10.1001/jamacardio.2020.5212

Table 2. Estimated Prevalence and Number of US Adults With Masked Asleep Hypertension.

Variable JNC7 definition 2017 ACC-AHA definition
Prevalence, % (95% CI) No. of US adults (95% CI), million Prevalence, % (95% CI) No. of US adults (95% CI), million
Overall 18.8 (16.7-20.8) 44.4 (39.1-49.7) 22.7 (20.6-24.8) 53.7 (47.9-59.6)
Antihypertensive use
No 16.4 (14.1-18.7) 29.8 (25.3-34.4) 22.2 (19.6-24.7) 40.2 (35.0-45.5)
Yes 26.5 (22.5-30.4) 14.6 (12.2-17.0) 24.4 (21.1-27.8) 13.5 (11.3-15.6)
Masked daytime hypertension
No 14.7 (12.8-16.6) 28.2 (24.1-32.3) 16.8 (14.8-18.8) 31.5 (27.1-35.8)
Yes 36.7 (32.2-41.2) 16.2 (13.4-19.0) 44.7 (40.1-49.3) 22.3 (18.9-25.7)
Sex
Male 23.7 (20.5-26.9) 27.1 (23.1-31.0) 27.0 (24.1-29.9) 30.8 (27.0-34.6)
Female 14.2 (12.2-16.2) 17.4 (14.8-19.9) 18.7 (16.2-21.2) 22.9 (19.7-26.2)
Age, y
18-44 12.4 (9.5-15.2) 13.8 (10.5-17.0) 20.0 (16.5-23.5) 22.2 (18.2-26.3)
45-64 23.0 (20.2-25.8) 18.9 (16.3-21.5) 25.5 (22.8-28.2) 20.9 (18.2-23.6)
≥65 27.2 (23.0-31.4) 11.8 (9.7-13.9) 24.4 (20.7-28.0) 10.6 (8.7-12.5)
Race/ethnicity
Non-Hispanic White 17.2 (14.6-19.8) 26.4 (21.3-31.5) 22.1 (19.5-24.7) 34.0 (28.4-39.5)
Non-Hispanic Black 28.8 (25.2-32.3) 7.9 (6.3-9.4) 28.7 (25.4-32.0) 7.9 (6.4-9.4)
Hispanic 18.2 (14.8-21.6) 6.5 (4.9-8.1) 21.9 (18.4-25.4) 7.8 (6.0-9.6)
Other 18.2 (11.4-25.0) 3.7 (2.2-5.1) 20.4 (14.1-26.7) 4.1 (2.7-5.5)
Diabetes
No 16.8 (14.7-18.9) 34.8 (29.9-39.6) 22.0 (19.6-24.3) 45.5 (40.0-51.0)
Yes 32.4 (27.5-37.3) 9.7 (8.1-11.3) 27.6 (23.5-31.8) 8.2 (6.9-9.6)
Obesity
No 17.0 (14.6-19.3) 25.2 (21.4-29.0) 21.7 (19.1-24.3) 32.3 (27.9-36.6)
Yes 21.8 (19.0-24.7) 19.2 (16.5-21.9) 24.3 (21.8-26.9) 21.4 (18.8-24.1)
Chronic kidney disease
No 17.2 (15.1-19.3) 34.8 (30.2-39.3) 22.9 (20.6-25.2) 46.3 (41.0-51.6)
Yes 27.9 (22.9-33.0) 9.7 (7.7-11.6) 21.5 (17.3-25.6) 7.4 (5.9-9.0)

Abbreviations: ACC-AHA, American College of Cardiology–American Heart Association; JNC7, Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.